Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

Recommendations for Second-Generation Tyrosine Kinase Inhibitors As Frontline Therapy in the Management of Chronic Myeloid Leukemia

Recommendations for Second-Generation Tyrosine Kinase Inhibitors As Frontline Therapy in the Management of Chronic Myeloid Leukemia

patient care perspectives
By Mark J. Levis, MD, PhD

Multiple Myeloma: Immunomodulatory Agents in the Evolving Treatment Paradigm

Multiple Myeloma: Immunomodulatory Agents in the Evolving Treatment Paradigm

patient care perspectives
By Kenneth C. Anderson, MD

Recommended Maintenance Therapy for Multiple Myeloma: Transplant and Nontransplant Settings

Recommended Maintenance Therapy for Multiple Myeloma: Transplant and Nontransplant Settings

expert roundtables
By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP, FASCO

The Evolving Role of Immunomodulatory Agents in Multiple Myeloma

The Evolving Role of Immunomodulatory Agents in Multiple Myeloma

expert roundtables
By Kenneth C. Anderson, MD; S. Vincent Rajkumar, MD; Sagar Lonial, MD, FACP, FASCO

Safety and Tolerability of Long-Term, Continuous Treatment for Multiple Myeloma

Safety and Tolerability of Long-Term, Continuous Treatment for Multiple Myeloma

patient care perspectives
By Sagar Lonial, MD, FACP, FASCO

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?